AIM Thomas K. Equels bought AIM ImmunoTech Inc. shares — SEC Form 4BUYAIM ImmunoTech Inc.

Thomas K. Equels, CEO & President at AIM ImmunoTech Inc. (AIM), bought 103 shares at $8.70 ($896) on 2025-06-12, disclosed to the SEC on 2025-06-13.

SEC EDGAR Filing

0001641172-25-015005

View on SEC EDGAR

Trade context

Open-market purchase of $896 AIM by CEO & President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.

Modest58/100

Nothing distinguishes this filing.

Minimal Holdings IncreaseOpportunistic BuyDeep Dip BuyMomentum Buy

Filing Info

Filed2025-06-13

Traded2025-06-12

Accession0001641172-25-015005

Sourcesec_form345

Insider

NameThomas K. Equels

TitleCEO & President

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
AIM	BUY	2026-09-18	$5K	—	Filing →
AIM	BUY	2026-09-17	$2K	—

Get an email when an insider at AIM files

Free account. Follow AIM and up to 10 more companies.

Follow AIM for free

AIM Thomas K. Equels bought AIM ImmunoTech Inc. shares — SEC Form 4BUYAIM ImmunoTech Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes